GGrantIndex
← Leaderboards

Giovanni Ferrari

Children'S Hosp Of Philadelphia

$11,594,575
Attributed
$17,849,705
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.4M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,849,705 · 8

By mechanism

R01$16,850,547 · 7
RC1$999,158 · 1

Top collaborators

Most similar at Children'S Hosp Of Philadelphia

Same institution · by research overlap

Others in their field

Top investigators on “Operative Surgical Procedures

Research focus

Operative Surgical ProceduresIn VitroHeart ValvesFunctional DisorderCellsSignal TransductionBiomechanicsMediatingAffectProductionProgramsIn VivoTissuesPhenotypeExperimental StudyRepairedHeart Valve DiseasesCardiacAortic ValveMitral ValveMethodologyBaseExtracellular MatrixCalcification

Grant awards (29)

Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$790,183
R01 · FY2025 · HL
Mitigation Strategies for Metabolic Syndrome-induced Bioprosthetic Heart Valve Degeneration$764,402
R01 · FY2025 · HL · contact PI
Decoupling mitral valve-left ventricular fibrotic remodeling in degenerative mitral regurgitation via serotonin 2B receptor$759,030
R01 · FY2025 · HL
An expandable polymeric valved conduit to repair congenital heart disease$546,993
R01 · FY2025 · HL · contact PI
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery$525,318
R01 · FY2025 · HL · contact PI
Mitigation Strategies for Metabolic Syndrome-induced Bioprosthetic Heart Valve Degeneration$780,527
R01 · FY2024 · HL · contact PI
Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$697,910
R01 · FY2024 · HL
Revision to Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery$569,377
R01 · FY2024 · HL · contact PI
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery$514,812
R01 · FY2024 · HL · contact PI
Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$721,824
R01 · FY2023 · HL
Supplement to Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$594,951
R01 · FY2023 · HL
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery$542,206
R01 · FY2023 · HL · contact PI
Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$731,206
R01 · FY2022 · HL
Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$791,513
R01 · FY2021 · HL
Oxidation-mediated structural degeneration of bioprosthetic heart valves$765,816
R01 · FY2021 · HL
Oxidation-mediated structural degeneration of bioprosthetic heart valves$785,792
R01 · FY2020 · HL
Oxidation-mediated structural degeneration of bioprosthetic heart valves$809,825
R01 · FY2019 · HL
Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$648,985
R01 · FY2019 · HL
Role of Rage in Bicuspid Aortic Valve Symdrome$402,030
R01 · FY2019 · HL · contact PI
Oxidation-mediated structural degeneration of bioprosthetic heart valves$846,165
R01 · FY2018 · HL
Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$657,068
R01 · FY2018 · HL
Role of Rage in Bicuspid Aortic Valve Symdrome$408,100
R01 · FY2018 · HL · contact PI
Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$664,532
R01 · FY2017 · HL
Role of Rage in Bicuspid Aortic Valve Symdrome$294,326
R01 · FY2017 · HL · contact PI
Role of RAGE in Bicuspid Aortic Valve Syndrome$113,774
R01 · FY2017 · HL · contact PI
Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration$700,532
R01 · FY2016 · HL
Role of RAGE in Bicuspid Aortic Valve Syndrome$423,350
R01 · FY2016 · HL · contact PI
Osteopontin: a Novel Biomarker for Calcific Aortic Valve Diseases$499,969
RC1 · FY2010 · HL · contact PI
Osteopontin: a Novel Biomarker for Calcific Aortic Valve Diseases$499,189
RC1 · FY2009 · HL · contact PI